» Articles » PMID: 17339438

Migration of CD4 T Cells and Dendritic Cells Toward Sphingosine 1-phosphate (S1P) is Mediated by Different Receptor Subtypes: S1P Regulates the Functions of Murine Mature Dendritic Cells Via S1P Receptor Type 3

Overview
Journal J Immunol
Date 2007 Mar 7
PMID 17339438
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Dendritic cells (DCs) and lymphocytes are known to show a migratory response to the phospholipid mediator, sphingosine 1-phosphate (S1P). However, it is unclear whether the same S1P receptor subtype mediates the migration of lymphocytes and DCs toward S1P. In this study, we investigated the involvement of S1P receptor subtypes in S1P-induced migration of CD4 T cells and bone marrow-derived DCs in mice. A potent S1P receptor agonist, the (S)-enantiomer of FTY720-phosphate [(S)-FTY720-P], at 0.1 nM or higher and a selective S1P receptor type 1 (S1P(1)) agonist, SEW2871, at 0.1 muM or higher induced a dose-dependent down-regulation of S1P(1). The pretreatment with these compounds resulted in a significant inhibition of mouse CD4 T cell migration toward S1P. Thus, it is revealed that CD4 T cell migration toward S1P is highly dependent on S1P(1). Mature DCs, when compared with CD4 T cells or immature DCs, expressed a relatively higher level of S1P(3) mRNA. S1P at 10-1000 nM induced a marked migration and significantly enhanced the endocytosis of FITC-dextran in mature but not immature DCs. Pretreatment with (S)-FTY720-P at 0.1 microM or higher resulted in a significant inhibition of S1P-induced migration and endocytosis in mature DCs, whereas SEW2871 up to 100 microM did not show any clear effect. Moreover, we found that S1P-induced migration and endocytosis were at an extremely low level in mature DCs prepared from S1P(3)-knockout mice. These results indicate that S1P regulates migration and endocytosis of murine mature DCs via S1P(3) but not S1P(1).

Citing Articles

Regulatory role of S1P and its receptors in sepsis-induced liver injury.

Wang B, Wu X, Cheng J, Ye J, Zhu H, Liu X Front Immunol. 2025; 16:1489015.

PMID: 39935473 PMC: 11811114. DOI: 10.3389/fimmu.2025.1489015.


Landscape transcriptomic analysis of bovine follicular cells during key phases of ovarian follicular development.

Mogollon Garcia H, de Andrade Ferrazza R, Ochoa J, de Athayde F, Vidigal P, Wiltbank M Biol Res. 2024; 57(1):76.

PMID: 39468655 PMC: 11514973. DOI: 10.1186/s40659-024-00558-2.


Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy.

Sukocheva O, Neganova M, Aleksandrova Y, Burcher J, Chugunova E, Fan R Cell Commun Signal. 2024; 22(1):251.

PMID: 38698424 PMC: 11064425. DOI: 10.1186/s12964-024-01626-6.


Myeloid Cells and Sphingosine-1-Phosphate Are Required for TCRαβ Intraepithelial Lymphocyte Recruitment to the Colon Epithelium.

Danielson S, Lefferts A, Norman E, Regner E, Schulz H, Sansone-Poe D J Immunol. 2024; 212(11):1843-1854.

PMID: 38568091 PMC: 11105980. DOI: 10.4049/jimmunol.2200556.


Differential effects of selective versus unselective sphingosine 1-phosphate receptor modulators on T- and B-cell response to SARS-CoV-2 vaccination.

Proschmann U, Mueller-Enz M, Woopen C, Al Rahbani G, Haase R, Dillenseger A Mult Scler. 2023; 29(14):1849-1859.

PMID: 37776101 PMC: 10687795. DOI: 10.1177/13524585231200719.